| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10834207 | Molecular Genetics and Metabolism | 2005 | 7 Pages | 
Abstract
												A six-month-old infant girl presenting with progressive encephalopathy and abnormal myelination in the cerebral white matter was originally diagnosed as suffering from Krabbe disease. The diagnosis was based on a deficiency of galactocerebrosidase activity found in leukocytes isolated from whole blood. When cultured skin fibroblasts did not show a similar enzyme deficiency and sulphatide (stearoyl-1-14C) uptake indicated an abnormal storage of galactosylceramide, a deficiency of an activator was implied. A three base pair deletion was found in the saposin A coding sequence of the prosaposin gene leading to the deletion of a conserved valine at amino acid number 11 of the saposin A protein. This deletion in saposin A is proposed as the cause for the abnormal galactosylceramide metabolism in this infant. This is the first report of a saposin A mutation in humans leading to pathological consequences.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Biochemistry
												
											Authors
												Ronen Spiegel, Gideon Bach, Vivi Sury, Getu Mengistu, Bela Meidan, Stavit Shalev, Yona Shneor Yona Shneor, Hanna Mandel, Marsha Zeigler, 
											